Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-07

FDA Approved: DRONABINOL — Original Application (Camber Pharmaceuticals Inc)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original abbreviated new drug application for dronabinol (generic). The product is indicated for chemotherapy-induced nause…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronabinol (dronabinol)

Snippet

ORIG AP for DRONABINOL (DRONABINOL)